X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18) 18
male (17) 17
oncology (14) 14
index medicus (13) 13
tumors (11) 11
adult (9) 9
middle aged (9) 9
cancer (8) 8
cisplatin (8) 8
malalties del testicle (8) 8
testis diseases (8) 8
antineoplastic agents (7) 7
càncer (7) 7
medicaments antineoplàstics (7) 7
prognosis (7) 7
animals (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
chemotherapy (6) 6
cisplatí (6) 6
mice (6) 6
neoplasms, germ cell and embryonal - drug therapy (6) 6
adolescent (5) 5
cisplatin - administration & dosage (5) 5
aged (4) 4
antineoplastic agents - pharmacology (4) 4
blotting, western (4) 4
breast cancer (4) 4
cancer chemotherapy (4) 4
disease models, animal (4) 4
drug resistance (4) 4
expression (4) 4
female (4) 4
mice, nude (4) 4
neoplasms (4) 4
paclitaxel - administration & dosage (4) 4
resistència als medicaments (4) 4
testicular cancer (4) 4
testicular neoplasms - drug therapy (4) 4
testicular neoplasms - pathology (4) 4
angiogenesis (3) 3
angiogenesis inhibitors - pharmacology (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antitumor-activity (3) 3
carboplatin (3) 3
catalan language (3) 3
cell line, tumor (3) 3
colorectal cancer (3) 3
consensus (3) 3
disease-free survival (3) 3
germ cell tumors (3) 3
lengua catalana (3) 3
neoplasms, germ cell and embryonal - mortality (3) 3
neoplasms, germ cell and embryonal - pathology (3) 3
paclitaxel (3) 3
quimioteràpia del càncer (3) 3
real-time polymerase chain reaction (3) 3
research article (3) 3
societies, medical (3) 3
testicular neoplasms - diagnosis (3) 3
urology (3) 3
xenograft model antitumor assays (3) 3
analysis (2) 2
angiogènesi (2) 2
antineoplastic agents - administration & dosage (2) 2
biopsy (2) 2
cancer research (2) 2
care and treatment (2) 2
cell survival - drug effects (2) 2
cisplatin - pharmacology (2) 2
clinical medicine (2) 2
combined modality therapy - methods (2) 2
combined modality therapy - standards (2) 2
consensus development conferences as topic (2) 2
docetaxel (2) 2
doxorubicin (2) 2
etoposide - administration & dosage (2) 2
europe (2) 2
female genital diseases and pregnancy complications (2) 2
gemcitabine (2) 2
gene expression (2) 2
genetics (2) 2
growth-factor (2) 2
high-dose chemotherapy (2) 2
historia (2) 2
history (2) 2
in-vitro (2) 2
inorganic chemicals (2) 2
interdisciplinary communication (2) 2
kinases (2) 2
klinisk medicin (2) 2
lapatinib (2) 2
lexicología (2) 2
life sciences (2) 2
long-term survivors (2) 2
lung cancer (2) 2
lung-cancer (2) 2
lymph-node dissection (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
metastasis (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medicina Clinica, ISSN 0025-7753, 02/2018, Volume 150, Issue 4, pp. 138 - 140
Background and objective: Five years’ data relative survival (RS) is presented in 3 solid tumours: breast, colorectal (CRC) and lung and 2 haematologic... 
Survival results | Breast cancer | Myeloma | Lung cancer | Colorectal cancer
Journal Article
Medicina Clinica, ISSN 0025-7753, 11/2010, Volume 135, Issue 13, pp. 598 - 599
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 2014, Volume 20, Issue 3, pp. 658 - 667
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2009, Volume 15, Issue 10, pp. 3384 - 3395
Purpose: Germ cell tumors (GCT) of the testis are highly curable, but those patients who are refractory to cisplatin (CDDP)-based combination chemotherapy have... 
sunitinib | cisplatin | angiogenesis | testicular germ cell tumors | MANAGEMENT | EFFICACY | ANGIOGENESIS | ONCOLOGY | TYROSINE KINASE INHIBITOR | ANTITUMOR-ACTIVITY | MARKED INCREASE | FACTOR RECEPTOR | EXPRESSION | SU11248 | CHEMOTHERAPY | Apoptosis - drug effects | Humans | Drug Resistance, Neoplasm | Male | Indoles - administration & dosage | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Receptors, Vascular Endothelial Growth Factor - metabolism | Pyrroles - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Indoles - pharmacology | Neoplasms, Germ Cell and Embryonal - drug therapy | Neovascularization, Pathologic - prevention & control | Receptors, Vascular Endothelial Growth Factor - genetics | Pyrroles - therapeutic use | Cell Survival - drug effects | Neoplasms, Germ Cell and Embryonal - blood supply | Angiogenesis Inhibitors - pharmacology | Receptors, Platelet-Derived Growth Factor - genetics | Cisplatin - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Synergism | Xenograft Model Antitumor Assays | Pyrroles - pharmacology | Animals | Testicular Neoplasms - drug therapy | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice, Nude | Receptors, Platelet-Derived Growth Factor - metabolism | Testicular Neoplasms - blood supply | Survival Analysis | Cell Line, Tumor | Indoles - therapeutic use | Neovascularization, Pathologic - genetics | Cell Proliferation - drug effects | Mice | Neovascularization, Pathologic - metabolism | Neoplasms, Germ Cell and Embryonal - pathology | Index Medicus | Malalties del testicle | Càncer | Cancer chemotherapy | Cisplatí | Quimioteràpia del càncer | Medicaments antineoplàstics | Testis diseases | Antineoplastic agents | Cisplatin | Tumors | Cancer
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 07/2013, Volume 133, Issue 1, pp. 235 - 246
In this work, we have analyzed the expression of different members of the ErbB family in human samples of testicular germ cell tumors (GCTs). We observed... 
lapatinib | testicular germ cell tumors | ErbBs | ErbB3 | FACTOR RECEPTOR INHIBITION | MONOCLONAL-ANTIBODY | BREAST-CANCER CELLS | LUNG-CANCER | IN-VITRO | ONCOLOGY | ZD1839 IRESSA | RESISTANCE | TYROSINE KINASE INHIBITOR | EXPRESSION | CARCINOMA | Endodermal Sinus Tumor - drug therapy | Immunoprecipitation | Humans | Male | Transplantation, Heterologous | Carcinoma, Embryonal - metabolism | Choriocarcinoma - metabolism | Receptor, Epidermal Growth Factor - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal - drug therapy | Antineoplastic Agents - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Gene Expression Regulation, Neoplastic - drug effects | Phosphorylation - drug effects | Cetuximab | Real-Time Polymerase Chain Reaction | Cell Survival - drug effects | Teratocarcinoma - metabolism | Testicular Neoplasms - metabolism | Receptor, ErbB-3 - antagonists & inhibitors | Neoplasms, Germ Cell and Embryonal - metabolism | Teratocarcinoma - drug therapy | Blotting, Western | Choriocarcinoma - drug therapy | Endodermal Sinus Tumor - metabolism | Animals | Testicular Neoplasms - drug therapy | Mice, Nude | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Protein Kinase Inhibitors - pharmacology | Quinazolines - pharmacology | Carcinoma, Embryonal - drug therapy | Antimitotic agents | Antineoplastic agents | Analysis | Tumors | Phosphorylation | Kinases | Testicular cancer | Index Medicus | Malalties del testicle | Cell receptors | Càncer | Medicaments antineoplàstics | Testis diseases | Receptors cel·lulars | Cancer
Journal Article
Journal Article
British Journal of Cancer, ISSN 0007-0920, 03/2003, Volume 88, Issue 6, pp. 879 - 886
This study was undertaken to investigate the expression and predictive value for outcome of multidrug resistance-associated (MDR) proteins P-glycoprotein... 
P-glycoprotein | Lung resistance-related protein | Multidrug resistance-associated protein 1 | Testicular germ-cell tumours | Breast cancer resistance protein | Multidrug resistance | PROGNOSTIC FACTORS | multidrug resistance | breast cancer resistance protein | ACUTE MYELOID-LEUKEMIA | DRUG-RESISTANCE | multidrug resistance-associated protein 1 | OVARIAN-CARCINOMA | lung resistance-related protein | MAJOR VAULT PROTEIN | NORMAL HUMAN TISSUES | ONCOLOGY | testicular germ-cell tumours | MALIGNANT TERATOMA | MULTIDRUG-RESISTANCE | MONOCLONAL-ANTIBODIES | Immunohistochemistry | Prognosis | Drug Resistance, Multiple | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Testicular Neoplasms - pathology | Cisplatin - administration & dosage | Testicular Neoplasms - surgery | Germinoma - genetics | Adult | Germinoma - surgery | Testicular Neoplasms - genetics | Germinoma - drug therapy | Neoplasm Proteins - biosynthesis | Antineoplastic Combined Chemotherapy Protocols | ATP-Binding Cassette, Sub-Family B, Member 1 - biosynthesis | Orchiectomy | Disease-Free Survival | ATP-Binding Cassette, Sub-Family B, Member 1 - analysis | Germinoma - pathology | Testicular Neoplasms - drug therapy | Adolescent | Neoplasm Proteins - analysis | Vault Ribonucleoprotein Particles - biosynthesis | Malalties del testicle | Germ cells | Resistència als medicaments | Cèl·lules germinals | Proteïnes supressores de tumors | Testis diseases | Gene expression | Drug resistance | Expressió gènica | Tumors | Tumor suppressor protein | Molecular and Cellular Pathology
Journal Article
Human mutation, ISSN 1059-7794, 2002, Volume 19, Issue 3, pp. 307 - 307
Journal Article
British Journal of Cancer, ISSN 0007-0920, 02/2002, Volume 86, Issue 3, pp. 326 - 330
Journal Article
Journal Article